| Literature DB >> 26774925 |
Nalmala Devender1, Sarika Gunjan2, Stuti Chhabra3, Kartikey Singh1, Venkata Reddy Pasam1, Sanjeev K Shukla4, Abhisheak Sharma5, Swati Jaiswal5, Sunil Kumar Singh6, Yogesh Kumar3, Jawahar Lal5, Arun Kumar Trivedi3, Renu Tripathi7, Rama Pati Tripathi8.
Abstract
In a quest to discover new drugs, we have synthesized a series of novel β-amino alcohol grafted 1,2,3-triazoles and screened them for their in vitro antiplasmodial and in vivo antimalarial activity. Among them, compounds 16 and 25 showed potent activity against chloroquine-sensitive (Pf3D7) strain with IC50 of 0.87 and 0.3 μM respectively, while compounds 7 and 13 exhibited better activity in vitro than the reference drug against chloroquine-resistance strain (PfK1) with IC50 of 0.5 μM each. Compound 25 showed 86.8% in vivo antimalarial efficacy with favorable pharmacokinetic parameters. Mechanistic studies divulged that potent compounds significantly boosted p53 protein levels to exhibit the antimalarial activity.Entities:
Keywords: Antimalarial; Antiplasmodial; Pharmacokinetics; p53 protein upregulation; β-aminoalcohol
Mesh:
Substances:
Year: 2015 PMID: 26774925 DOI: 10.1016/j.ejmech.2015.12.038
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514